Five years of clinical application of independent Monte Carlo-based patient-specific quality assurance at Maastro Proton Therapy Center
- Journal
- Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) (Q2)
- Published
- 10 September 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Ilaria Rinaldi, Giorgio Cartechini, Angelo Schiavi, Jan Gajewski, Nils Krah, Antoni Rucinski, et al.
- PMID
- 42721498
- DOI
- 10.1016/j.ejmp.2026.107195
Why clinicians should know about it
- Picked for Medical Physics (top studies of the week, 13 September 2026).
Abstract
INTRODUCTION: At the Maastro Proton Therapy Center in Maastricht, patient-specific quality assurance (PSQA) based on independent GPU-accelerated Monte Carlo (MC) dose calculations fully replaces conventional measurements. Measurement-based PSQA is time- and resource-intensive and has limited sensitivity to clinically relevant errors. We developed a fully automated MC-based pipeline integrating two clinical workflows using the fast MC code FRED. The system is fully operational, and automated verification reports are used in daily clinical practice. METHODS: The first workflow performs pre-treatment dose recalculation in FRED using the original clinical treatment plan. The second workflow combines FRED with machine log files to verify the delivered dose. Both workflows generate automated verification reports for clinical review. RESULTS: The workflow has been routinely used for over five years, providing robust 3D dosimetric verification in heterogeneous patient anatomies. More than 6000 pre-treatment plans and 3272 log file-based PSQA cases were analyzed, corresponding to a reduction of 4090 h of routine QA. The pipeline identified all true negatives and detected two pre-treatment failures related to planning issues that would have been missed by conventional measurement-based PSQA. No false positives or false negatives were observed, demonstrating high sensitivity and reliability. CONCLUSIONS: The MC recalculation pipeline provides an efficient PSQA solution for proton therapy. Five years of experience confirm that measurement-free MC-based PSQA is a viable and superior alternative, offering comprehensive 3D verification and early error detection while reducing the clinical workload. This work may serve as a practical reference for implementation at other proton therapy centers.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.